About
3.89USD+0.00 +0.00%
Closed • Updated at 13:08 GMT+00:00Market Cap$300.26M
Volume666.6K
Beta2.28
RSI58.93
Eledon Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 20 2026
Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
May 13 2026
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
Apr 20 2026
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
Mar 19 2026
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
Mar 16 2026
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
Recent Videos

Hear from Eledon Chief Scientific Officer Dr. Steve Perrin about their Type 1 Diabetes program.
May 12, 2026

Eledon Update: Patient #1!
May 07, 2026

Eledon Trial: Katie Beth Update
May 06, 2026

Why Eledon is changing the world. On a cellular level
May 04, 2026
Community Chat
Ask AI
Try asking
Google Übersetzer